Looking Toward the Future: Myeloma Center Celebrates 35th Anniversary

By Nathan Tidwell

The Myeloma Center, located in the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), has firmly established itself as an international leader in myeloma treatment. From its beginnings in 1989, UAMS’ myeloma program is recognized for detailed patient care, groundbreaking research and pioneering advances in the management of myeloma and its related conditions.

From the Total Therapy approach, the introduction of tandem autologous transplants, the creation of a prediction model for stem cell collection and the current implementation of innovative immunotherapies, the path towards a cure for myeloma continues — with UAMS leading the way.

Myeloma Center Clinical Director Frits van Rhee, M.D., Ph.D., and his team embrace the task of developing new methods of treating this disease.

Looking Toward the Future: Myeloma Center Celebrates 35th Anniversary

Myeloma Center physicians Sharmilan Thanendrarajan, M.D., Ph.D., Samer Al Hadidi, , M.D., clinical director Frits van Rhee, M.D., Ph.D., Carolina Schinke, M.D., and Maurizio Zangari, M.D. Image by Bryan Clifton